questionText: To ask the Secretary of State for Health and Social Care, pursuant to the Answer of 23 July 2025 to Question 68387 on Epilepsy and Pregnancy: Sodium Valproate, whether his Department plans to (a) mandate central tracking and annual reporting on how many women (i) received the Pregnancy Protection Porgramme and (ii) signed the risk acknowledgement form.
answerText: NHS England has worked collaboratively with the Medicines and Healthcare products Regulatory Agency (MHRA) on the safer use of valproate containing medicines.There are no plans to mandate central tracking and annual reporting on how many women (i) receive...
heading: Sodium Valproate